FDA Inspection 751395 — Cantrell Drug Company

Cantrell Drug Company — FEI 3004483441

The FDA completed an inspection of Cantrell Drug Company on Oct 21, 2011 in Little Rock, AR. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Oct 21, 2011
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Little Rock, AR (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.